Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
I-Mab ADR - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
IMAB
Nasdaq
2834
https://www.i-mabbiopharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for I-Mab ADR
I-Mab Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
- Mar 18th, 2024 10:49 am
I-Mab Reports Full Year 2023 Financial Results and Business Update
- Mar 14th, 2024 9:00 pm
Q4 2023 Summit Therapeutics Inc Earnings Call
- Feb 21st, 2024 6:56 am
UPDATE 2-Biotech firm I-Mab to divest China operations, shift focus to US
- Feb 7th, 2024 11:29 am
I-Mab Signs Agreement to Divest its Assets and Business Operations in China
- Feb 7th, 2024 11:00 am
Individual investors account for 41% of I-Mab's (NASDAQ:IMAB) ownership, while private equity firms account for 26%
- Nov 19th, 2023 2:45 pm
I-Mab Announces Participation at Jefferies and Piper Conferences in November
- Nov 6th, 2023 1:00 pm
Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)
- Nov 2nd, 2023 12:00 pm
I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023
- Nov 1st, 2023 12:00 pm
I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023
- Oct 16th, 2023 12:00 pm
I-Mab and ABL Bio Announce Latest Updates of PD-L1 and 4-1BB Bispecific Antibody TJ-L14B/ABL503
- Oct 10th, 2023 12:00 pm
Ray Dalio on Potential US-China War and Rise of China
- Oct 5th, 2023 9:17 pm
UPDATE 1-AbbVie terminates deal with I-Mab to develop cancer drug
- Sep 22nd, 2023 9:03 pm
I-Mab Announces Upcoming Participation at September Conferences
- Sep 5th, 2023 12:00 pm
I-Mab (NASDAQ:IMAB) Q2 2023 Earnings Call Transcript
- Aug 18th, 2023 2:55 pm
Half Year 2023 I-Mab Earnings Call
- Aug 18th, 2023 2:30 am
I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates
- Aug 17th, 2023 10:00 am
I-Mab to Report Mid-Year 2023 Financial Results, Business and Corporate Updates on August 17, 2023
- Aug 8th, 2023 12:00 pm
I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC
- Jul 5th, 2023 12:00 pm
I-Mab Announces the Appointment of Raj Kannan as CEO
- Jun 22nd, 2023 12:00 pm
Scroll